-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
September 03, 2019 - g Cardiovascular risk score of 4 or greater: established coronary heart disease (4 points), arterial … Effects of raloxifene on
cardiovascular events and breast cancer in
postmenopausal women. … Raloxifene and
cardiovascular events in osteoporotic
postmenopausal women: four-year results from
the … Year-by-year analysis of cardiovascular events in the
Multiple Outcomes of Raloxifene Evaluation
(MORE … Cardiovascular
effects of tamoxifen in women with and without
heart disease: Breast Cancer Prevention
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/e9f8a_uGMXxSbBUxpRPkrc
June 18, 2024 - , functioning, depression, medical events or condi-
tions that may be associated with high BMI [eg, cardiovascular … Health outcomes, including quality of life, depression, and
cardiovascular-related morbidity or mortality … suggest
that high BMI in childhood is associated with an increased risk
of premature mortality and cardiovascular … Childhood cardiovascular risk factors and adult
cardiovascular events. … What
change in body mass index is required to improve
cardiovascular outcomes in childhood and
adolescent
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-pregnant-women1/human-immunodeficiency-virus-hiv-infection-screening
June 11, 2019 - Cardiovascular Congenital Anomalies
The 2012 USPSTF review included 1 cohort study 60 (n = 382) that … publications) also reported mixed results for the association between in utero ART exposure and adverse cardiovascular … significant association between in utero exposure to currently recommended ART drugs and increased risk of cardiovascular … study (n = 214,240) found no significant association between ART exposure during the first trimester on cardiovascular … especially in the first trimester, was associated with echocardiographic abnormalities without significant cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary11/carotid-artery-stenosis-screening-december-2007
December 15, 2007 - Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the … The Cardiovascular Health Study. Stroke 1998;29:2371-6. … Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular … The Cardiovascular Health Study. … The Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation 1994;90:2905-8.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/impaired-visual-acuity-screening-older-adults
May 24, 2022 - sham treatment groups. 6 , 24 , 27 , 44 The studies were not sufficiently powered to assess rates of cardiovascular … Three trials (n = 2738; reported in 2 publications) found that serious ocular adverse events and cardiovascular … One area of concern with VEGF inhibitors has been a potential association with increased risk of cardiovascular … events. 76 Although randomized trials of VEGF inhibitors for AMD did not report increased risk of cardiovascular … to either aflibercept or ranibizumab
Consistent
Imprecise
Trials not powered for serious cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/tobacco-use-intervention-prevention-cessation-children-adolescents
June 27, 2024 - severity of asthma, chronic bronchitis, or other respiratory disorders, dental and oral health outcomes, cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertensive-disorders-pregnancy-screening
September 19, 2023 - Million Hearts is a national initiative that provides tools and resources for cardiovascular health, … particularly preeclampsia) is associated with an increased risk of maternal chronic hypertension and cardiovascular … Tools and Resources
Million Hearts is a national initiative that provides tools and resources for cardiovascular … low-dose aspirin prophylaxis, if indicated, initiated at the recommended gestational age
To mitigate cardiovascular … Long-term cardiovascular risk in women with hypertension during pregnancy.
-
www.uspreventiveservicestaskforce.org/uspstf/document/behavioral-counseling-and-pharmacotherapy-interventions-for-/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
September 21, 2015 - None of the drugs were associated with major cardiovascular adverse events. … event, driven predominantly by minor cardiovascular events, such as tachycardia and arrhythmia. 49 … Although 2 reviews found no evidence of an increased risk for any or major cardiovascular adverse events … Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. … Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation:
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-screening-1996
January 01, 1996 - left untreated, as many as one third of patients progress to have potentially severe late gummatous, cardiovascular … , and neurologic complications. 3 Cardiovascular syphilis produces aortic disease (insufficiency, aneurysms
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/LNtA2SDWjpsDwjXvsH4F5m
April 17, 2023 - particularly preeclampsia)
is associated with an increased risk of maternal chronic hyperten-
sion and cardiovascular … • Million Hearts is a national initiative that provides tools and resources for cardiovascular health … Tools and Resources
Million Hearts is a national initiative that provides tools and re-
sources for cardiovascular … low-dose aspirin prophylaxis, if indicated, initiated at the recom-
mended gestational age
• To mitigate cardiovascular … Long-term cardiovascular risk in women with
hypertension during pregnancy.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
November 01, 2013 - There were no significant differences in the
incidence of osteoporosis, cardiovascular events, other … Study outcomes included throm-
boembolic events, uterine abnormalities, cardiovascular
disease events … Raloxifene and cardiovascular events in osteoporotic postmenopausal
women: four-year results from the … Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in
postmenopausal women … Effects of
raloxifene on cardiovascular events and breast cancer in postmenopausal women.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obstructive-sleep-apnea-in-adults-screening
March 04, 2021 - measures, such as the 36-Item Short-Form Health Survey), measures of sleepiness, motor vehicle crashes, cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ph_fauqHQjmrSqPAWKrARA
September 28, 2021 - A number of cohort studies have found associations between pre-
eclampsia and long-term cardiovascular … Prenatal exposure to preeclampsia as an
independent risk factor for long-term
cardiovascular morbidity … Cardiovascular risk factors in children and young
adults born to preeclamptic pregnancies:
a systematic … Preeclampsia and hypertensive disease in
pregnancy: their contributions to cardiovascular
risk. … Hypertensive pregnancy
disorders and subsequent cardiovascular morbidity
and type 2 diabetes mellitus
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/tobacco-cessation-adults-interventions
July 17, 2025 - Tobacco-related mortality
Tobacco-related morbidity (including but not limited to cancer, asthma, cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MeDkbyweVDHdpNgerFahn4
January 01, 2010 - activity) is one
of the strongest risk factors for many chronic
diseases and conditions, including cardiovascular … Twenty-
nine percent of patients reported potential
cardiovascular events during the 2 years. … Physician advice and individual behaviors about
cardiovascular disease risk reduction: seven states and … Randomised controlled
trial evaluating cardiovascular screening and
intervention in general practice: … Physical activity and cardiovascular risk
factors: effect of advice from an exercise specialist in
Australian
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medications-for-risk-reduction
July 20, 2017 - certain medications)
KQs 3, 4: Adverse effects (including but not limited to: thromboembolic events, cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cAs__BR8J4rgcZ4vQgfaTx
April 01, 2009 - See the Clinician Fact Sheet titled Using Aspirin For the
Primary Prevention of Cardiovascular Disease
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/food-insecurity-screening
July 28, 2022 - outcomes (e.g., low birth weight, developmental outcomes in children, incident diabetes, mental health, cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/B73a4kJhxeaYyXK6gozbbY
May 24, 2022 - treatment groups.6,24,27,44 The studies were not sufficiently pow-
ered to assess rates of cardiovascular … Three trials (n = 2738; reported in 2 publications) found that seri-
ous ocular adverse events and cardiovascular … One area of concern with
VEGF inhibitors has been a potential association with increased risk
of cardiovascular … events.76 Although randomized trials of VEGF in-
hibitors for AMD did not report increased risk of cardiovascular … randomized to either aflibercept or ranibizumab
Consistent
Imprecise
Trials not powered for serious
cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
May 15, 2009 - In addition to NTDs, the cohort and meta-analysis found reductions in cardiovascular congenital abnormalities … , this study also reported that women who received supplements had infants with significantly fewer cardiovascular … Reference)
Outcomes
Results
Notes
Czeizel et al, 2004 4
NTDs, abnormalities of urinary tract, cardiovascular … 0.11 (CI, 0.01-0.91)
Urinary tract congenital abnormalities: adjusted OR, 0.71 (CI, 0.33-1.50)
Cardiovascular … in case-control studies, 0.48 (CI, 0.30-0.76); OR in RCTs and cohort studies, 0.68 (CI, 0.35-1.31)
Cardiovascular